Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients.
Serum immunoglobulin levels were studied in 153 psychiatric patients (87 schizophrenic, 48 bipolar and 18 unipolar patients), and 35 healthy controls. Psychotropic treatments (haloperidol in the schizophrenic patients and lithium in the bipolar affective patients) did not alter serum immunoglobulin levels. Decreased mean IgM serum level was detected in the major affective patients (unipolar and bipolar) compared with normal controls. Nonspecific environmental, infectious, autoimmune and emotional factors that can play a role in the alterations obtained in psychiatric patients are discussed.
Spivak
B
B
Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, Israel.
Radwan
M
M
Bartur
P
P
Brandon
J
J
Tyano
S
S
Weizman
A
A
D000293:Adolescent; D000328:Adult; D001714:Bipolar Disorder / Q000276:immunology* / Q000523:psychology; D002908:Chronic Disease; D003866:Depressive Disorder / Q000276:immunology* / Q000523:psychology; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage*; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism*; D016651:Lithium Carbonate / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000276:immunology*; D012565:Schizophrenic Psychology
D007136:Immunoglobulins; D016651:Lithium Carbonate; D006220:Haloperidol